| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Annual report on equity, diversity, and inclusion: Research and Practice in Thrombosis and Haemostasis is meeting its goals
|
Pendlebury, Elizabeth C.
|
|
|
5 |
7 |
p.
|
artikel
|
| 2 |
A quality‐of‐life questionnaire for heavy menstrual bleeding in Thai women receiving oral antithrombotics: Assessment of the translated Menstrual Bleeding Questionnaire
|
Rodpetch, Tinaram
|
|
|
5 |
7 |
p.
|
artikel
|
| 3 |
Association between transportation barriers and anticoagulation control among an inner‐city, low‐income population: A prospective observational cohort study
|
Yan, Connie H.
|
|
|
5 |
7 |
p.
|
artikel
|
| 4 |
External qualification of the Web‐Accessible Population Pharmacokinetic Service–Hemophilia (WAPPS‐Hemo) models for octocog alfa using real patient data
|
Chelle, Pierre
|
|
|
5 |
7 |
p.
|
artikel
|
| 5 |
Falsely positive heparin‐induced thrombocytopenia antibody testing in severe hyperbilirubinemia
|
Egert, Daniel
|
|
|
5 |
7 |
p.
|
artikel
|
| 6 |
Global coagulation assays in patients with diabetes mellitus
|
Lim, Hui Yin
|
|
|
5 |
7 |
p.
|
artikel
|
| 7 |
Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay
|
Morimont, Laure
|
|
|
5 |
7 |
p.
|
artikel
|
| 8 |
Issue Information
|
|
|
|
5 |
7 |
p.
|
artikel
|
| 9 |
Magnetic resonance imaging in boys with severe hemophilia A: Serial and end‐of‐study findings from the Canadian Hemophilia Primary Prophylaxis Study
|
Stimec, Jennifer
|
|
|
5 |
7 |
p.
|
artikel
|
| 10 |
Prevalence of anti–platelet factor 4/polyanionic antibodies after COVID‐19 vaccination with ChAdOx1 nCoV‐19 and CoronaVac in Thais
|
Noikongdee, Phichchapha
|
|
|
5 |
7 |
p.
|
artikel
|
| 11 |
Quality of life in adolescents with heavy menstrual bleeding: Validation of the Adolescent Menstrual Bleeding Questionnaire (aMBQ)
|
Pike, Meghan
|
|
|
5 |
7 |
p.
|
artikel
|
| 12 |
Recombinant factor IX‐Fc fusion protein in severe hemophilia B: Patient‐reported outcomes and health‐related quality of life
|
O’Donovan, Mairead
|
|
|
5 |
7 |
p.
|
artikel
|
| 13 |
Rivaroxaban‐calibrated chromogenic anti‐Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulation
|
Lucas, Fabienne
|
|
|
5 |
7 |
p.
|
artikel
|
| 14 |
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
|
Speed, Victoria
|
|
|
5 |
7 |
p.
|
artikel
|
| 15 |
Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis
|
Camilleri, Eleonora
|
|
|
5 |
7 |
p.
|
artikel
|
| 16 |
The impact of extended half‐life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B
|
Sun, Haowei (Linda)
|
|
|
5 |
7 |
p.
|
artikel
|
| 17 |
The path of uncovering a prothrombotic thrombocytopenic syndrome after viral vector‐based COVID‐19 vaccination: Where there is much light, the shadow is deep
|
Thaler, Johannes
|
|
|
5 |
7 |
p.
|
artikel
|
Tijdschrift beschrijving